News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
378,619 Results
Type
Article (15352)
Company Profile (123)
Press Release (363144)
Section
Business (116762)
Career Advice (463)
Deals (19278)
Drug Delivery (30)
Drug Development (33157)
Employer Resources (52)
FDA (9282)
Job Trends (8018)
News (180305)
Policy (13141)
Tag
2024 BioCapital Digital (2)
2024 BioForest Digital (6)
2024 BioMidwest Digital (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (9)
2024 Biotech Beach Digital (3)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (1)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (3)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (3)
2026 BioCapital Elite (1)
2026 Biotech Bay Standard (1)
2026 Genetown Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (1486)
Adcomms (1)
Allergies (36)
Alliances (35452)
ALS (21)
Alzheimer's disease (518)
Antibody-drug conjugate (ADC) (55)
Approvals (9285)
Artificial intelligence (217)
Autoimmune disease (1)
Automation (11)
Bankruptcy (142)
Best Places to Work (6784)
BIOSECURE Act (7)
Biosimilars (9)
Biotechnology (93)
Bladder cancer (24)
Brain cancer (11)
Breast cancer (103)
Cancer (883)
Cardiovascular disease (59)
Career advice (411)
Career pathing (8)
CAR-T (93)
Cell therapy (268)
Cervical cancer (6)
Clinical research (25926)
Collaboration (540)
Compensation (100)
Complete response letters (3)
COVID-19 (1204)
CRISPR (34)
C-suite (118)
Cystic fibrosis (47)
Data (855)
Decentralized trials (1)
Denatured (18)
Depression (15)
Diabetes (86)
Diagnostics (4914)
Digital health (15)
Diversity (4)
Diversity, equity & inclusion (10)
Drug discovery (71)
Drug pricing (14)
Drug shortages (4)
Duchenne muscular dystrophy (19)
Earnings (40137)
Editorial (2)
Employer branding (8)
Employer resources (45)
Events (53419)
Executive appointments (354)
FDA (9825)
Featured Employer (28)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (1)
Funding (431)
Gene editing (81)
Generative AI (23)
Gene therapy (182)
GLP-1 (215)
Government (1295)
Grass and pollen (1)
Guidances (24)
Healthcare (10626)
Huntington's disease (7)
IgA nephropathy (8)
Immunology and inflammation (25)
Indications (9)
Infectious disease (1273)
Inflammatory bowel disease (58)
Inflation Reduction Act (3)
Influenza (30)
Intellectual property (47)
Interviews (52)
IPO (8250)
IRA (8)
Job creations (1523)
Job search strategy (367)
Kidney cancer (3)
Labor market (8)
Layoffs (121)
Leadership (3)
Legal (2747)
Liver cancer (35)
Lung cancer (111)
Lymphoma (54)
Machine learning (2)
Management (17)
Manufacturing (159)
MASH (15)
Medical device (11812)
Medtech (11817)
Mergers & acquisitions (11316)
Metabolic disorders (193)
Multiple sclerosis (25)
NASH (3)
Neurodegenerative disease (26)
Neuropsychiatric disorders (2)
Neuroscience (697)
NextGen: Class of 2025 (3763)
Non-profit (1619)
Northern California (1005)
Now hiring (8)
Obesity (84)
Opinion (77)
Ovarian cancer (32)
Pain (49)
Pancreatic cancer (38)
Parkinson's disease (61)
Partnered (10)
Patents (117)
Patient recruitment (47)
Peanut (25)
People (33916)
Pharmaceutical (16)
Phase I (9414)
Phase II (11679)
Phase III (7695)
Pipeline (400)
Podcasts (38)
Policy (28)
Postmarket research (622)
Preclinical (4282)
Press Release (66)
Prostate cancer (36)
Psychedelics (4)
Radiopharmaceuticals (154)
Rare diseases (137)
Real estate (3511)
Recruiting (21)
Regulatory (9812)
Reports (18)
Research institute (1317)
Resumes & cover letters (69)
Rett syndrome (2)
RNA editing (1)
RSV (20)
Schizophrenia (13)
Series A (78)
Series B (47)
Service/supplier (7)
Sickle cell disease (18)
Southern California (1074)
Special edition (1)
Sponsored (13)
Startups (2555)
State (2)
Stomach cancer (1)
Supply chain (22)
The Weekly (19)
United States (10680)
Vaccines (312)
Venture capitalists (18)
Webinars (7)
Weight loss (37)
Women's health (16)
Worklife (2)
Date
Today (86)
Last 7 days (319)
Last 30 days (1556)
Last 365 days (18641)
2025 (3428)
2024 (19389)
2023 (22844)
2022 (31774)
2021 (33564)
2020 (31613)
2019 (26888)
2018 (20312)
2017 (19565)
2016 (18435)
2015 (21420)
2014 (15990)
2013 (13368)
2012 (14481)
2011 (14829)
2010 (13522)
Location
Africa (327)
Alabama (36)
Alaska (7)
Arizona (113)
Arkansas (10)
Asia (24586)
Australia (4309)
California (2608)
Canada (965)
China (203)
Colorado (151)
Connecticut (127)
Delaware (35)
Europe (50642)
Florida (454)
Georgia (127)
Idaho (37)
Illinois (260)
India (10)
Indiana (153)
Iowa (4)
Japan (92)
Kansas (80)
Kentucky (6)
Louisiana (5)
Maine (20)
Maryland (437)
Massachusetts (1856)
Michigan (176)
Minnesota (233)
Mississippi (2)
Missouri (53)
Montana (28)
Nebraska (15)
Nevada (19)
New Hampshire (65)
New Jersey (820)
New Mexico (15)
New York (765)
North Carolina (546)
North Dakota (7)
Northern California (1005)
Ohio (100)
Oklahoma (10)
Oregon (18)
Pennsylvania (597)
Puerto Rico (6)
Rhode Island (19)
South America (521)
South Carolina (14)
South Dakota (1)
Southern California (1074)
Tennessee (54)
Texas (427)
Utah (97)
Virginia (51)
Washington D.C. (11)
Washington State (303)
West Virginia (3)
Wisconsin (33)
378,619 Results for "ortho regenerative technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Group FH ORTHO announced the Launch of JARVIS the New Round Baseplate for Reverse Prosthesis in the USA!
January 20, 2025
·
2 min read
Business
Ortho Regenerative Technologies Announces Corporate Name Change to ChitogenX
Ortho Regenerative Technologies Inc. announced that it has changed its corporate name to ChitogenX Inc. to better reflect the Company’s expanded clinical and commercial opportunities, mission, values, and core competencies.
September 7, 2022
·
3 min read
Press Releases
Hemostemix’s Social Media Awareness of “Your Fountain of Youth"(TM) Regenerative Medicine Treatments Is Gaining Traction
Hemostemix is revolutionizing how individuals think about their own regenerative medicine treatments. With social media, the company is educating individuals about treatments and advancements.
January 2, 2025
·
6 min read
Biotech Beach
THINK Surgical to Collaborate with b-ONE Ortho Corporation for Robotic TKA
THINK Surgical, Inc. announced that it will enter into a new Collaboration Agreement with b-ONE Ortho Corporation.
February 14, 2024
·
3 min read
Business
Harvard Apparatus Regenerative Technology Reports First Quarter 2024 Financial Results and Recent Business Highlights
Harvard Apparatus Regenerative Technology, Inc. (OTCQB: HRGN) (“Harvard Apparatus Regenerative Technology” or the “Company”), a clinical-stage biotechnology company developing the technology to regenerate organs inside the body to treat severe diseases, today reported first quarter 2024 financial results.
May 13, 2024
·
6 min read
Ortho Development Receives FDA Clearance on Trivicta Hip System
Ortho Development Corporation, a designer and manufacturer of orthopedic implants and instruments for hip and knee joint replacement surgery, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Trivicta™ Hip System.
March 14, 2024
·
1 min read
ORTHO REGENERATIVE TECHNOLOGIES RECEIVES $500,000 AXELYS GRANT TO ADVANCE ORTHO-M DEVELOPMENT FOR MENISCUS REPAIR
Ortho Regenerative Technologies Inc. announced today that it has received, through its partnership with Polytechnique Montreal, a $500,000 non-dilutive grant from Axelys, to advance the development of its second technology platform indication, ORTHO-M, for meniscus repair.
May 26, 2022
·
3 min read
ORTHO REGENERATIVE TECHNOLOGIES RECEIVES KEY U.S. COMPOSITION AND METHOD PATENT FOR ORTHO-R SOFT TISSUE REPAIR PLATFORM
Ortho Regenerative Technologies Inc. announced today that the United States Patent and Trademark Office (the “USPTO”) has issued a patent related to the Company’s ORTHO-R soft tissue repair platform.
May 4, 2022
·
3 min read
Business
ORTHO REGENERATIVE TECHNOLOGIES ANNOUNCES EXECUTIVE LEADERSHIP CHANGES
Ortho Regenerative Technologies Inc. today announced the appointment of Philippe Deschamps as its new Chief Executive Officer following the retirement of Mr. LeDuc, the Company’s CEO for the last three years.
March 15, 2022
·
5 min read
Business
Harvard Apparatus Regenerative Technology Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
Harvard Apparatus Regenerative Technology, Inc. (OTCQB: HRGN) (“Harvard Apparatus Regenerative Technology” or the “Company”), a clinical-stage biotechnology company developing the technology to regenerate organs inside the body to treat severe diseases, today reported fourth quarter and full year 2023 financial results.
April 2, 2024
·
9 min read
1 of 37,862
Next
